POSTER: MDS-838: Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
Year: 2026
Type: article
Authors: Rami Komrokji, Maria Diez Campelo, Shuh Ying Tan, David Valcarcel Ferreiras, Anish Puliyayil, Alejandro Arbelaez, Montserrat Arnan, David MRoss, Devendra Hiwase, Teresa Bernal del Castillo, Thomas Cluzeau, Aristoteles Giagounidis, Mikkael A Sekeres, Andrew S Artz, Radha Ramesh, Camden Bay, Kevin Galinsky, Leopold Sellner, Kaveri Suryanarayan, Lynette CY Chee
Institutions: Moffitt Cancer Center, Instituto de Investigación Biomédica de Salamanca, St Vincent's Hospital Melbourne, Vall d'Hebron Hospital Universitari, Albury Wodonga Health, Institut Català d'Oncologia, Flinders Medical Centre, Royal Adelaide Hospital, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Centre Hospitalier Universitaire de Nice, Marien Hospital Düsseldorf, University of Miami, Sylvester Comprehensive Cancer Center, City Of Hope National Medical Center, City of Hope, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204691729